{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:07Z","timestamp":1786119607486,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/mbc.0b013e328340e690","type":"journal-article","created":{"date-parts":[[2010,11,13]],"date-time":"2010-11-13T04:17:18Z","timestamp":1289621838000},"page":"34-39","source":"Crossref","is-referenced-by-count":4,"title":["Perioperative bridging therapy with low molecular weight heparin for patients with inherited thrombophilia and antiphospholipid syndrome on long-term acenokumarol therapy"],"prefix":"10.1097","volume":"22","author":[{"given":"Adam","family":"Wiszniewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Szopi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Ratajczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rados\u0142aw","family":"Bilski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ksenia","family":"Bykowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210203","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1001\/archinte.1992.00400200092017","article-title":"The prevalence of risk factors for venous thromboembolism among hospital patients","volume":"152","author":"Anderson","year":"1992","journal-title":"Arch Intern Med"},{"key":"R2-7-20210203","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0741-5214(94)70188-1","article-title":"Prevention of venous thromboembolism in North America: results of survey among general surgery","volume":"20","author":"Caprini","year":"1994","journal-title":"J Vasc Surg"},{"issue":"suppl.","key":"R3-7-20210203","doi-asserted-by":"crossref","first-page":"531S","DOI":"10.1378\/chest.114.5_Supplement.531S","article-title":"Prevention of venous thromboembolism","volume":"114","author":"Clagett","year":"1998","journal-title":"Chest"},{"key":"R4-7-20210203","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/archinte.162.11.1245","article-title":"Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study","volume":"162","author":"Heit","year":"2002","journal-title":"Arch Intern Med"},{"key":"R5-7-20210203","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch Intern Med"},{"key":"R6-7-20210203","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(86)91158-X","article-title":"Preoperative identification of patients at high risk of deep venous thrombosis after elective major abdominal surgery","volume":"1","author":"Sue-Ling","year":"1986","journal-title":"Lancet"},{"key":"R7-7-20210203","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/bmj.302.6778.709","article-title":"Incidence of venous thromboembolism verified by necropsy over 30 years","volume":"302","author":"Lindblad","year":"1991","journal-title":"BMJ"},{"key":"R8-7-20210203","first-page":"1410","article-title":"Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool","volume":"88","author":"Samama","year":"2003","journal-title":"Haematologica"},{"key":"R9-7-20210203","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1067\/mva.2002.121749","article-title":"The prevalence of thrombophilia in patients with chronic venous leg ulceration","volume":"35","author":"MacKenzie","year":"2002","journal-title":"J Vasc Surg"},{"key":"R10-7-20210203","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1055\/s-0038-1650551","article-title":"Deep venous thrombosis and lupus anticoagulant","volume":"76","author":"Simioni","year":"1996","journal-title":"Thromb Haemost"},{"key":"R11-7-20210203","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2257.1999.00210.x","article-title":"The investigation and management of inherited thrombophilia","volume":"21","author":"Cumming","year":"1999","journal-title":"Clin Lab Haemat"},{"key":"R12-7-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/00033197050560i101","article-title":"Thrombophilia and venous thromboembolism. International Consensus Statement. Guidelines according to scientific evidence","volume":"24","author":"Nicolaides","year":"2005","journal-title":"Int Angiol"},{"key":"R13-7-20210203","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/mp.53.6.300","article-title":"Thrombophilia, polymorphisms and vascular disease","volume":"53","author":"Sykes","year":"2000","journal-title":"Mol Pathol"},{"key":"R15-7-20210203","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/blood-2002-11-3334","article-title":"Antibeta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome","volume":"102","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"R16-7-20210203","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9343(98)00060-6","article-title":"Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group","volume":"104","author":"Schulman","year":"1998","journal-title":"Am J Med"},{"key":"R17-7-20210203","first-page":"991","article-title":"Preoperative assessment of individual thrombotic risk levels in patients with varicose veins of the lower limbs","volume":"11","author":"Wiszniewski","year":"2002","journal-title":"Polish J Surg"},{"key":"R18-7-20210203","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1378\/chest.08-0761","article-title":"Venous thromboembolism, thrombophilia, antithrombotic therapy and pregnancy: American College of Chest Physicans Evidence-Based Clinical Practice guidelines (8th Edition)","volume":"133","author":"Bates","year":"2008","journal-title":"Chest"},{"key":"R19-7-20210203","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1378\/chest.08-0675","article-title":"The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"133","author":"Douketis","year":"2008","journal-title":"Chest"},{"issue":"6 suppl","key":"R20-7-20210203","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American College of chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest"},{"key":"R21-7-20210203","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/archinte.164.12.1319","article-title":"LMWH as bridging anticoagulation during interruption of warfarin","volume":"164","author":"Douketis","year":"2004","journal-title":"Arch Intern Med"},{"key":"R22-7-20210203","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1160\/TH05-01-0064","article-title":"Bridging anticoagulation with LMWH after interruption of warfarin therapy is associated with a residual anticoagulation effect prior to surgery","volume":"94","author":"Douketis","year":"2005","journal-title":"Thromb Haemost"},{"key":"R23-7-20210203","doi-asserted-by":"crossref","first-page":"488a","DOI":"10.1182\/blood.V104.11.1761.1761","article-title":"Perioperative bridging therapy with enoxaparin in patients requiring interruption of long-term oral anticoagulant therapy: a multicenter cohort study","volume":"104","author":"Dunn","year":"2004","journal-title":"Blood"},{"key":"R24-7-20210203","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/archinte.163.8.901","article-title":"Perioperative management of patients receiving oral anticoagulants: a systemic review","volume":"163","author":"Dunn","year":"2003","journal-title":"Arch Intern Med"},{"key":"R25-7-20210203","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1012746729537","article-title":"Perioperative management of the chronically anticoagulated patient","volume":"12","author":"Heit","year":"2001","journal-title":"J Thromb Thrombolysis"},{"issue":"suppl.1","key":"R26-7-20210203","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3949\/ccjm.73.Suppl_1.S100","article-title":"Anticoagulation management strategies for patients on warfarin who need surgery","volume":"73","author":"Jaffer","year":"2006","journal-title":"Cleveland Clin J Med"},{"key":"R27-7-20210203","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/0003-4819-146-3-200702060-00007","article-title":"Brief communication: preoperative anticoagulant activity after bridging LMWH for temporary anticoagulation","volume":"146","author":"O'Donell","year":"2007","journal-title":"Ann Intern Med"},{"key":"R28-7-20210203","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.disamonth.2005.03.014","article-title":"Perioperative bridging therapy for the at risk patient on chronic anticoagulation","volume":"51","author":"Spyropoulos","year":"2005","journal-title":"Dis Mon"},{"key":"R29-7-20210203","first-page":"373","article-title":"Perioperative bridging interruption with heparin for the patient receiving long term anticoagulation","volume":"11","author":"Spyropoulos","year":"2005","journal-title":"Curr Opin Pulm Med"},{"key":"R30-7-20210203","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1161\/01.CIR.0000142859.77578.C9","article-title":"Single arm study of bridging therapy with LMWH for patients at risk of arterial embolism who require temporary interruption of warfarin","volume":"110","author":"Kovacs","year":"2004","journal-title":"Circulation"},{"key":"R31-7-20210203","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/heart.89.5.527","article-title":"Experience with enoxaparin in patients with mechanical heart valves who must withhold acenokumarol","volume":"89","author":"Ferreira","year":"2003","journal-title":"Heart"},{"key":"R32-7-20210203","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11239-005-3120-9","article-title":"Low molecular weight heparins as periprocedural anticoagulation for patients on long term warfarin therapy. A standardized bridging therapy protocol","volume":"20","author":"Jaffer","year":"2005","journal-title":"J Thromb Thrombolysis"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001721-201101000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:42:07Z","timestamp":1786041727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-201101000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e328340e690","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}